Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers

BACKGROUND: We investigated the effects and safety of linagliptin as an add-on therapy in patients with advanced-stage diabetic nephropathy (DMN) taking renin–angiotensin–aldosterone system (RAAS) blockers. METHOD: Twenty advanced-stage DMN patients (estimated glomerular filtration rate (eGFR): 24.5...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Target Insights
Autores principales: Ueda, Yuichiro, Ishii, Hiroki, Kitano, Taisuke, Shindo, Mitsutoshi, Miyazawa, Haruhisa, Ito, Kiyonori, Hirai, Keiji, Kaku, Yoshio, Mori, Honami, Hoshino, Taro, Ookawara, Susumu, Kakei, Masafumi, Tabei, Kaoru, Morishita, Yoshiyuki
Formato: Artigo
Lenguaje:Inglês
Publicado: Libertas Academica 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019128/
https://ncbi.nlm.nih.gov/pubmed/27660406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/DTI.S38339
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares